Radiation Therapy for Neovascular Age-related Macular Degeneration By: Mehran Taban, MD; Darius Moshfeghi, MD; Rishi P. Singh, M.D. Immune-Based Therapy With Glatiramer Acetate for Dry AMD By: Gennady Landa, MD; Oleg Butovsky, PhD; Johai Shoshani, MD; Michal Schwartz, PhD; Ayala Pollack, MD Drug Delivery to the Retina Using Intravitreal Aerosolized Nanoparticles By: Timothy W. Olsen, MD Are Antioxidant Vitamins and Minerals Dangerous? The Role of Antioxidants, Minerals, and Nutrition in AMD By: Emily Y. Chew, M.D. Photo Essay: Recurrent Toxoplasma Chorioretinitis With Kyrieleis' Vasculitis By: Anne E. Fung, MD; David Heiden, MD; Sarah Huggans; Denice Barsness A Look at the New Vitreoretinal Surgical Codes By: Riva Lee Asbell Revolutionary changes have taken place Upfront From the editor-in-chief EVRS Editorial By: Giampaolo Gini, MD The EVRS: surgeons coming together to learn Subspecialty News VEGF-Trap in second phase 3 study and more Coding Q&A By: Riva Lee Asbell Here’s help on 3 rather tricky billing questions Products & Services Events Calendar Clinical Trial Spotlight By: Andrew E. Mathis, PhD, Medical Editor Implant may reduce ranibizumab injections Clinical Trials Update Current Issue: June 2008
		| © Lippincott Williams & Wilkins VisionCare Group All Rights Reserved - Terms and Conditions of Service